DRUG SG&A Expense Growth
Bright Minds Biosciences Inc · SG&A Expense Growth
DRUG SG&A Expense Growth
Latest reported77.47%period ending
DRUG FY SG&A Growth (YoY) (0.00% → 77.47%)
Latest values, visible window
High-resolution chart · PNG
DRUG sg&a expense growth history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 77.4682% | |
| -34.2868% | |
| -13.7689% | |
| 10.4777% | |
| 1,823.0899% | |
| 9.0353% | |
| 0% |